Angel Seafood Holdings - IPO Opens for Bids

EverBlu Capital opened the Initial Public Offering for Angel Seafood Holdings Limited. Angel is seeking to raise $6-8 million through the issue of up to 40 million shares at an offer price of $0.20

Angel farms clean, green, organic and sustainable oysters which it sells domestically and internationally. The Company currently owns or leases 41.08 hectares of oyster production licenses and leases in South Australia and has agreed to acquire a further 10.00 hectares of oyster production licenses and leases.

The Company believes it has identified a unique opportunity to rapidly expand operations through the aggregation of a number of smaller oyster farms into one entity so it can become the largest producer of organic and sustainable Pacific oysters in Australia. 

Some of the Key Highlights include:

  • Certified Organic Pacific Oyster Producer and certified as a "Friends of the Sea" Pacific Oyster Producer
  • Ideal Geographic Location in South Australia in the Eyre Peninsula
  • Proven Profitability since 2010 (except FY16/17 due to rapid expansion)
  • Large footprint of a large percentage of all available water leases in the area
  • Highly skilled team with a lot of experience operating in oyster production
  • Already existing export distribution networks into Hong Kong and Singapore
  • High demand that exceeds current supply capacity for the entire industry with domestic prices rising steadily year on year
  • High Barriers to Entry

The offer opened on Monday 18 December with the offer to remain open until January unless closed early at discretion of the Company. A listing date is expected to be in February 2018.

For more information please use the following links:

quote

"We are very excited about the launch of anibidiol in Switzerland and thrilled to be working in partnership with Virbac, such a well-established global company in the animal health field."

"When coupled with the very exciting partnership with Kingdom that gives Creso a strategic foothold in China and Asia. These are very ezxciting developments for us as a company and are important steps in our plans for growth in key markets and sectors."

CRESO PHARMA CEO, DR. MIRI HALPERIN WERNLI

What we do at EverBlu Capital Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum erat leo, lobortis ut dapibus id, tincidunt ac erat. Phasellus placerat fermentum elit at cursus. Nunc pellentesque lectus sed nibh tempor.

EverBlu Corporate

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum erat leo, lobortis ut dapibus id, tincidunt ac erat. Phasellus placerat fermentum elit at cursus. Nunc pellentesque lectus sed nibh tempor, eu auctor arcu dignissim. In euismod luctus ligula id dignissim vivamus lorem ipsum dolor sit amet…

Learn more

EverBlu Wealth

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum erat leo, lobortis ut dapibus id, tincidunt ac erat. Phasellus placerat fermentum elit at cursus. Nunc pellentesque lectus sed nibh tempor, eu auctor arcu dignissim. In euismod luctus ligula id dignissim vivamus lorem ipsum dolor sit amet…

Learn more

EverBlu Research

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum erat leo, lobortis ut dapibus id, tincidunt ac erat. Phasellus placerat fermentum elit at cursus. Nunc pellentesque lectus sed nibh tempor, eu auctor arcu dignissim. In euismod luctus ligula id dignissim vivamus lorem ipsum dolor sit amet…

Learn more

%

GROWTH TOP-LINE REVENUES

M

AUSTRALIAN DOLLARS RAISED

TOMBSTONES LOREM IPSUM

What they say about us

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

olore magna aliqua

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

olore magna aliqua